PHOTO
Abu Dhabi, United Arab Emirates: CPhI Middle East & Africa concluded today at the Abu Dhabi National Exhibition Centre (ADNEC) with a panel discussion addressing the UAEs commitment to becoming an innovative market while effectively managing healthcare spending in the region.
The panel discussion, titled Innovation versus Generics, was moderated by Dr. Suhasini M V, Principal Consultant Healthcare & Life Sciences – MEA, Frost & Sullivan, while panellists included Manel Chikh, CEO & Board Member, Zaphyr Pharmaceuticals; Claudia Palme, Senior Executive Advisor, Strategy&, part of the PwC Network; Shorab Khanduri, Director – Marketing & Sales, NPI Oman; and Hasan Kapar, Head of Commercial Excellence & operations, Gulf, GlaxoSmithKline.
Generics, which typically refer to drugs that contain the same active ingredients as branded equivalents, are launched to the market after the pharmaceutical manufacturer’s patent has expired often at a lower price and therefore creating cost efficiencies.
The panellists discussed the UAE’s commitment to become an innovative market whilst also being mindful of healthcare spending, they also discussed the longevity of substantial investment into domestic generics.
Dr Chikh, who is also the founder of Zaphyr Pharmaceuticals, said: “Government policies and efforts across the MEA region to reduce drug spending whilst simultaneously improving access to quality and cost-effective medicines for patients has resulted in the strong performance of generics. Affordability will be the key consideration for both payers and patients, and the most cost-effective options will typically be generics.
Research by CPhI MEA revealed in 2016 the UAE pharmaceutical market was worth US$3.17 billion, however a Compound Annual Growth Rate of 7.5% in the last three years has led experts to believe the value of the UAE pharma market could top over US$4.5 billion by 2021, well above the global CAGR of 5.8%.
CPhI Middle East and Africa, which was officially opened by His Excellency Sheikh Nahyan bin Mubarak al Nahyan, Minister of Tolerance, concludes today. Sponsored by the Ministry of Health and Protection (MoHaP), CPhI showcased over 290 exhibitors and attracted some 4,900 pharma professionals from around the world.
Cara Turner, Brand Director, CPhI Middle East & Africa, said: “After a successful launch in Abu Dhabi in 2018, we have cemented our position this year as the leading pharma event in the region. The continued support from MoHaP has further endorsed our decision to host the event in Abu Dhabi and we look forward to enhancing this partnership further as we aim to attract even greater numbers of high-level delegates, visitors, exhibitors and speakers next year.”
ENDS
About CPhI
CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, North America, Korea, China, India, Japan, Southeast Asia and the Middle East, and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, FDF for finished dosage formulations, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com.
For more information visit: www.cphi.com
About Informa Markets
Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com.
Media contact
JAMES LAKIE
General Manager
Tel: +971 4 365 2711 | Mobile: +971 50 153 6544
E-mail: james.lakie@shamalcomms.com
Office 106, Arjaan Office Tower, Dubai Media City
PO Box 502701 | Dubai, United Arab Emirates
Website: www.shamalcomms.com
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
